Renal sympathetic nerve denervation for the treatment of resistant hypertension

Abstract

Improvements in BP control with pharmacotherapy undoubtedly translate into significant individual and population health benefits. RDN results in impressive reductions in BP, which are likely to be associated with further improvements in clinical outcomes. With more clinical trials and concurrent development of new devices, we hope that RDN holds up to its current accolades.

Renal sympathetic denervation for resistant hypertension in a patient with a single kidney

“…To the Editor : We report a case of successful renal sympathetic denervation (RSD) treatment for resistant hypertension in a patient with a single kidney 1 . ‐ 3 RSD is performed via femoral arterial access, using a radiofrequency ablation catheter to deliver energy to the renal artery wall. When delivering RSD to a single kidney, potential renal artery vascular complications can have a significant negative impact on a patient's renal function, compared with patients with two functioning kidneys.…”